Form 4 holding
Director
Cyclerion Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 34,866
- Estimated value
- $118,370
- Report date
- 30 Nov 2023
- Price
- $3.40
- Ownership
- By Polaris Partners VIII, L.P
Terrance McGuire - Director at Cyclerion Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- CYCN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Terrance McGuire since 15 Aug 2025
Reported holdings for Terrance McGuire in Cyclerion Therapeutics, Inc.
Form 4 holding
Director
Cyclerion Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 5,552
- Estimated value
- $18,849
- Report date
- 30 Nov 2023
- Price
- $3.40
- Ownership
- Direct
Form 4 holding
Director
Cyclerion Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,247
- Estimated value
- $4,234
- Report date
- 30 Nov 2023
- Price
- $3.40
- Ownership
- By Polaris Entrepreneurs 'Fund VIII, L.P.
Form 4 holding
Director
Cyclerion Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 345
- Estimated value
- $1,171
- Report date
- 30 Nov 2023
- Price
- $3.40
- Ownership
- By Bartlett Partners, LLC
Transaction history for Terrance McGuire in Cyclerion Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.